Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0B9LI
|
||||
| Former ID |
DNC014463
|
||||
| Drug Name |
(+/-)-threo-N-(2-Methylpyridine)methylphenidate
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C20H24N2O2
|
||||
| Canonical SMILES |
COC(=O)C(C1CCCCN1CC2=CC=CC=N2)C3=CC=CC=C3
|
||||
| InChI |
1S/C20H24N2O2/c1-24-20(23)19(16-9-3-2-4-10-16)18-12-6-8-14-22(18)15-17-11-5-7-13-21-17/h2-5,7,9-11,13,18-19H,6,8,12,14-15H2,1H3/t18-,19-/m1/s1
|
||||
| InChIKey |
AZQUBJDTVAIXBC-RTBURBONSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Sodium-dependent dopamine transporter | Target Info | Inhibitor | [1] | |
| KEGG Pathway | Dopaminergic synapse | ||||
| Parkinson's disease | |||||
| Cocaine addiction | |||||
| Amphetamine addiction | |||||
| Alcoholism | |||||
| PANTHER Pathway | Adrenaline and noradrenaline biosynthesis | ||||
| Parkinson disease | |||||
| Dopamine receptor mediated signaling pathway | |||||
| Pathway Interaction Database | Alpha-synuclein signaling | ||||
| Reactome | Na+/Cl- dependent neurotransmitter transporters | ||||
| WikiPathways | Monoamine Transport | ||||
| NRF2 pathway | |||||
| Dopaminergic Neurogenesis | |||||
| Parkinsons Disease Pathway | |||||
| Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds | |||||
| Neurotransmitter Clearance In The Synaptic Cleft | |||||
| References | |||||
| REF 1 | Bioorg Med Chem. 2010 Oct 15;18(20):7221-38. Epub 2010 Aug 19.Quantitative structure-activity relationship studies of threo-methylphenidate analogs. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.